Nikhil Chari,


Nikhil Chari is Co-founder of Indiabulls Pharmaceuticals. Prior to co-founding Indiabulls Pharmaceuticals in 2016, Nikhil spent the last 18 years in strategy consulting and investing in leading healthcare corporations across the globe.

Nikhil started his career with leading strategy consulting firm, McKinsey & Company with their Global Pharmaceuticals Practice in New Jersey, USA and worked extensively with top global healthcare organizations across the pharmaceuticals, medical devices and healthcare services sectors.

Post his strategy consulting career, Nikhil spent the past decade with leading investment management firms as an investor in global healthcare corporations and worked closely with company Boards, government policy makers and regulators and industry stakeholders to shape the healthcare investment agenda across diverse geographies such as North America, Europe, Japan, Australia, Brazil, China, Russia, South Africa and India.

Nikhil is an MBA from The Wharton School at the University of Pennsylvania, Philadelphia, USA majoring in Finance and Healthcare Management and a Bachelors and Masters of Technology from the Indian Institute of Technology, Delhi majoring in Biochemical Engineering and Biotechnology. Nikhil is also a CFA charter holder.

Co-Founder’s message on the vision of the company
“At Indiabulls Pharmaceuticals we want to reshape the Indian Pharmaceutical industry landscape by providing next generation therapies to patients at previous generation prices. We aspire to be a patient and physician centric, innovative, best-in-class pharmaceutical company. With a proven and dynamic leadership team and a commitment to contribute to the Indian healthcare industry, we are poised to be a leading player in the coming decade”